Draft User Fee Bill’s GMP Shortcut for Shortage Drugs Is Balanced: Expert

Washington Drug Letter
Drugmakers may soon be able to get critical shortage drugs to market faster with a proposed shortcut for proving manufacturing compliance that’s included in draft legislation to reauthorize the FDA’s user fee programs.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00